Background and Objective: It is well known that recombinant human fibroblast
| INTRODUC TI ON
The alveolar ridge is absorbed after tooth extraction, often resulting in insufficient bone volume for functional and esthetic dental implant placement. 1, 2 To resolve these problems, soft and hard tissue augmentation procedures have been performed using connective tissue grafts, bone grafts, biologic membranes, or their combination. [3] [4] [5] [6] Recently, therapeutic growth factors have been introduced as tissue-inductive agents for ridge augmentation. [7] [8] [9] [10] [11] Recombinant human fibroblast growth factor-2 (rhFGF-2) has been investigated for the treatment of human intrabony periodontal defects. [12] [13] [14] [15] [16] [17] [18] [19] rhFGF-2 exerts high angiogenic potential and proliferation of undifferentiated mesenchymal cells is induced. 20, 21 Moreover, rhFGF-2 signaling plays an essential role in tissue repair and regeneration, especially in terms of osteogenesis.
22
Prolonging the release period of growth factors at regeneration sites is necessary for predictable tissue regeneration. [23] [24] [25] The optimal duration and concentration of controlled release of growth factors differ according to the amount and type of tissue to be regenerated. 26 In a periodontal defect model, rhFGF-2 affected cells that support periodontal regeneration in the very early phase after application, through the proliferation of fibroblastic cells, enhancement of angiogenesis, osteoblastic differentiation, and bone morphogenetic protein-2 (BMP-2) production. The study emphasized that rhFGF-2 plays an important role in early regeneration by creating a local environment favorable for periodontal regeneration.
However, this effect ended when rhFGF-2 disappeared from the administration site after one week. 21 Nevertheless, it is unclear whether this phenomenon remains the same for alveolar ridge augmentation.
The release period of growth factors is determined by their carrier. Gelatin has the unique characteristic that its electrical properties can be altered by a collagen processing method to achieve controlled release of growth factors. [26] [27] [28] rhFGF-2, which is basic in vivo, shows high affinity, binds ionically to acidic gelatin (IEP 5.0), and is released gradually when the gelatin decomposes. 29, 30 On the other hand, most rhFGF-2 is quickly released from basic gelatin (IEP 9.0) by simple desorption, because polyion complexation between rhFGF-2 and basic gelatin does not occur. 31 We previously reported that newly formed bone at sites treated with rhFGF-2 incorporated into acidic gelatin/β-TCP sponges (IEP 5.0) was significantly greater than that at sites treated with scaffolds alone in a ridge augmentation model in dogs. 33 We hypothesized that this significant outcome was obtained because of the high affinity of the gelatin/β-TCP sponge to rhFGF-2, prolonging its release at therapeutic sites. A comparison between acidic and basic gelatin/β-TCP sponges with different isoelectric points is needed to evaluate the efficacy of controlled rhFGF-2 release. However, no in vivo study has evaluated the efficacy of basic gelatin sponges with an IEP of 9.0 incorporating the controlled release of rhFGF-2 in bone regeneration.
In this study, we investigated the effects of controlled rhFGF-2 release by comparing acidic and basic gelatin/β-TCP sponges incorporating rhFGF-2 in a ridge augmentation model in dogs.
| MATERIAL AND ME THODS

| Preparation of gelatin/β-TCP sponges incorporating rhFGF-2
Biodegradable acidic and basic gelatin sponges (IEP, 5.0 and 9.0; Nitta Gelatin, Osaka, Japan) containing 50 wt% β-TCP (Taihei Chemical Industries, Nara, Japan) were prepared as described previously. 32 In brief, each solution of gelatin and β-TCP granules was mixed using a homogenizer (ED-12; Nihon Seiki, Tokyo, Japan) at 5000 rpm and 37°C for 3 min. Glutaraldehyde solution (0.16 wt%) were added to the mixture, and the solution was mixed for 15 s. Over the next 12 h, the solution was incubated in polypropylene dishes at 4°C for gelatin cross-linking. The sponges were then mixed with 100 mM/L glycine solution at 37°C for 1 h to block the residual glutaraldehyde. Finally, freezedried sponges were obtained after washing with double-distilled water. Freeze-dried rhFGF-2 (Kaken Pharmaceutical Co. Ltd, Tokyo, Japan) was dissolved to a concentration of 0.3% rhFGF-2 in phosphate-buffered saline solution (pH 7.4). Before application to the defects, the gelatin/β-TCP sponges were soaked in 100 μL of rhFGF-2 solution.
sections was significantly lower in the basic group than in the acidic group. The total tissue height was lower in the basic group than in the acidic group. However, the differences between both sites were not significant. Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan) at the operation area as a local anesthetic. Twelve weeks before the surgery, all maxillary second and third incisors were extracted to create the experimental defects apart from adjacent teeth. Twelve weeks later, the experimental ridge augmentation procedure was performed.
Conclusions
Under the same anesthesia, a full-thickness muco periosteal flap was elevated by a semilunar incision from the canine distal site to the first incisor mesial site beyond the muco gingival junction ( Figure 1A ). Saddle-type bone defects (8 mm length × 4 mm depth)
were surgically created bilaterally using a steel bar 2 mm mesial from the maxillary canine mesial site, removing all buccal-palatal alveolar ridges between them. The average buccal-lingual width was approximately 10 mm ( Figure 1B ). 33 Gelatin/β-TCP sponges were trimmed to match the size of the defects (8 mm length × 4 mm depth × 10 mm width) using a surgical knife. In the acidic group, acidic gelatin/β-TCP sponges (IEP 5.0) infiltrated with 0.3% rhFGF-2 (Kaken Pharmaceutical Co. Ltd, Tokyo, Japan) were applied to the defects ( Figure 1C ). In the basic group, basic gelatin/β-TCP sponges (IEP 9.0) infiltrated with 0.3% rhFGF-2 were applied. Each site was selected randomly (by a coin toss) from bilateral defects (split-mouth design).
The elevated flap was sutured tightly (Gore-Tex ® CV-6 Suture; W.L. Chemical Industries, Osaka, Japan) for morphological and histological observation.
| Micro computed tomography analysis
Before decalcification, all block specimens were scanned using a micro-CT system (inspeXio SMX-100CT; Shimadzu Corporation, Kyoto, Japan) at an electric current of 77 mA and a voltage of 85 kV.
Analysis software (TRI/ 3D-BON; Ratoc System Engineering Co., Ltd., Tokyo, Japan) converted the scanned data to two-dimensional 
| Histological analysis
Histological measurement was based on a previously reported method with a slight modification. 33 Briefly, after being trimmed, the specimens were decalcified for approximately 1 month in Plank-Rychlo's solution, dehydrated, and embedded in paraffin (HISTPREP 568, Wako Pure Chemical Industries Ltd., Osaka, Japan) and cut into 6-μm-thick sections on the sagittal plane.
The most central section of the defect was defined as the section 6 mm from the most mesial point of the maxilla canine. The most central parts of each section were selected (acidic group, n = 6; basic group, n = 6) and stained with hematoxylin and eosin.
Light microscopy (Eclipse Ni-U, Nikon Corporation, Tokyo, Japan; F I G U R E 1 Surgical procedure. After the elevation of a muco periosteal flaps (A), saddle-type bone defects (8 mm length × 4 mm depth) (B) were surgically created 2 mm mesial to the canine, removing all buccal-palatal alveolar ridges between them. The defects were filled with acidic gelatin/β-TCP sponges incorporating 0.3% rhFGF-2 in the acidic group and with basic sponges in the basic group (IEP of 5.0 and 9.0, respectively; C)
DP70, Olympus Corporation, Tokyo, Japan) was used for histological observations and analysis using a computerized image system consisting of a high-definition color camera head (DS-Fi2; Nikon Corporation) and a microscope camera control unit (DS-L3; Nikon Corporation) equipped with a measurement function. According to a previous study, new bone height (defined as the distance between the top of the new bone and the line connecting buccal and lingual tops of the host bone) and total tissue height (defined as the distance between the top of the soft tissue and the line connecting the buccal and lingual tops of the host bone) were calculated. 33 To minimize intra-examiner errors, two blinded, experienced examiners (T.A. and T.M.) conducted the measurements to obtain an average.
| Statistical analysis
Means and standard deviations for each parameter were calculated for each group. Sample distribution was investigated using 
| RE SULTS
| Clinical observations
There were no remarkable signs of infection or suppuration and no critical events such as exposure of the applied material at either site after the surgery. Both sites healed equally well throughout the study.
F I G U R E 2 Micro-CT image analysis. New bone area was defined as the percentage of new bone formation in the region of interest, a standardized rectangle (8 mm length × 4 mm depth; red box) in the 2-D images at the most central cross-section (mesiodistal and sagittal) of the defects. This rectangle consists of four points: The first and second points were on the line connecting the most distal point of the first incisor and the most mesial point of the canine, 2 and 10 mm away from the most mesial point of the canine. The other two points were on a line perpendicular to the preceding line, 4 mm from the first two points F I G U R E 3 Micro-CT images. In the acidic group, new bone-like radiopaque structures were observed in 3-D micro-CT images (A). In the acidic group, the new bone-like radiopaque structures were present not only near the surfaces of original bone, but also away from the original bone in the defects, as shown in 2-D images of mesiodistal sections from the middle of the defects (B). In the acidic group, the new bone-like radiopaque structures were higher, as observed in 2-D images of sagittal sections from the middle of the defects (C). In the basic group, remaining large bony defects were observed in 3-D micro-CT images (D). In the basic group, the new bone-like radiopaque structures were limited to areas near the original bone in the defects, as observed in 2-D images of mesiodistal sections (E). In the basic group, the height of the bone-like radiopaque structures was slightly lower, as observed in 2-D images of sagittal sections (F). Scale bars represent 10 mm
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| Micro-CT observation
Three-dimensional images were obtained from the micro-CT data ( Figure 3A,D) . In both groups, bone-like hard tissue was observed around the created defects. There was less newly formed bonelike hard tissue in the basic group than in the acidic group. 2-D images of the mesiodistal sections of the central parts of the defects were obtained from the micro-CT data ( Figure 3B,E) . Dome-shaped, dense, radiopaque structures were observed at the created defects in both groups. The heights of the dome-shaped structures were lower in the basic group than in the acidic group. 2-D images of sagittal sections of the central parts of the defects were also obtained ( Figure 3C ,F). Dense radiopaque findings were observed in the areas of the created bone defects in both groups. Bone crests at the bone defect sites were concave in both groups, but notably less concave in the basic group than in the acidic group. Table 1 shows the results of micro-CT analysis of new bone area. New bone area in the created bone defects in the acidic group (68.0 ± 8.70%) was significantly smaller than that in the basic group (80.9 ± 12.4%; P = 0.01).
| Histological observation
No signs of infection or acute inflammation were shown in histological sections of either group ( Figure 4A,D) . In the acidic group, domeshaped, bone-like tissue was observed. This tissue was denser than the original bone under it because of its small bone marrow space.
The height of the dome-shaped tissue in the basic group was lower than that in the acidic group. Mature, woven bone (WB) incorporating many blood vessels and a small bone marrow space in the alveolar ridge were observed ( Figure 4B ). WB was observed adjacent to the original lamellar bone (LB) at the border between the new bone and the original bone (white arrow; Figure 4C ). Mature WB incorporating vessels in the alveolar ridge were observed ( Figure 4E ). WB was observed adjacent to the original LB at the border between the new bone and the original bone (white arrow; Figure 4F ). Acidic and basic gelatin/β-TCP sponges had been completely absorbed at both sites after twelve weeks. Table 2 shows the results of histological analyses. New bone height in the basic group (2.88 ± 0.71 mm) was significantly lower than that in the acidic group (3.72 ± 0.58 mm; P = 0.04). However, total tissue height was not significantly different between the basic group (6.63 ± 0.87 mm) and the acidic group (7.11 ± 0.69 mm; P = 0.28).
TA B L E 1 Micro-CT analysis of new bone area
Parameters
Acidic group Basic group
New bone area (%) 80.9 ± 12.4* 68.0 ± 8.70
Student's t-test was used for paired observations. Results are given as means ± standard deviation. *Significant difference (P < 0.05); n = 6.
F I G U R E 4 Histological observation. In the acidic group, a large volume of bone-like hard tissue was formed continuous with the original bone (A). Woven bone (WB) incorporating blood vessels were observed in the alveolar ridge (B). WB continuous with original lamellar bone (LB) was observed at the border between the new bone and the original bone (white arrow; C). In the basic group, a small amount of bonelike hard tissue was formed continuous with original bone (D). Immature WB incorporating blood vessels observed in the alveolar ridge (E). WB continuous with original LB was observed at the border between new bone and original bone (white arrow; F). Scale bars represent 1 mm (A and D) and 100 μm (B, C, E, F)
| D ISCUSS I ON
The timing and duration of exposure of the growth factor to the lost tissue is important for regeneration. The present study evaluated the efficacy of controlled rhFGF-2 release by comparing acidic and basic gelatin/β-TCP sponges with IEPs of 5.0 or 9.0, respectively, incorporating rhFGF-2.
In vitro studies showed that acidic gelatin sponge (IEP 5.0) had a high affinity to rhFGF-2, which is basic in vivo, and formed gelatin complexes ionically. 29, 30 The effect of controlled rhFGF-2 release can be achieved by gelatin decomposition to enhance hard and soft tissue regeneration in in vivo studies. [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] On the contrary, in vitro studies have reported that basic gelatin sponges (IEP 9.0) rarely have an affinity to rhFGF-2 and do not exhibit polyion complexation 31 .
Therefore, basic gelatin sponges rarely act as scaffolds retaining rh-FGF-2. In the current study, the sites in the basic group likely only exposed rhFGF-2 to the defect at the time of sponge application. Compared to our previous study conducted under similar conditions, the amount of bone augmentation in the acidic group in the present study (total tissue height: 7.11 ± 0.69 mm; new bone height: 3.72 ± 0.58 mm) twelve weeks after operation was similar to the amount observed eight weeks after operation (total tissue height: 6.62 ± 0.66 mm; new bone height: 2.98 ± 0.65 mm).
In the present study, bone height in the basic group (total tissue height: 6.63 ± 0.87 mm; new bone height: 2.88 ± 0.71 mm) was slightly higher than that in our previous study using acidic gelatin/ β-TCP sponges (IEP 5.0) with normal saline (total tissue height:
5.95 ± 0.74 mm; new bone height: 1.56 ± 0.66 mm). 33 These results indicate that the effectiveness of rhFGF-2 release from basic gelatin/ β-TCP sponges (IEP 9.0) is detectable, albeit small. Histological observation showed that in the previous study, newly formed bone was still immature at eight weeks, while in the present study the regenerated bone in the present study was mature for additional four weeks.
The contained-type defects in the previous study using a threewall periodontal regeneration model showed a greater regenerative potential without the controlled release effects of rhFGF-2 in the early period. 21 The discrepancy between the results of the present study and the previous periodontal regeneration model could be explained by defect morphology. The defects in the present study
were not contained-type defects and required controlled release to stimulate osteogenesis and continuous bone regeneration. This tendency was similar to that in the previous report, despite the modification of the observation period. 33 The clinical use of rhFGF-2 for periodontal regeneration is gaining popularity and its effect is evident. New indications for ridge augmentation are under investigation in vivo. When evaluating the effect of rhFGF-2 on alveolar ridge augmentation, the affinity of the rhFGF-2 carrier should be considered because of its effects on controlled release and the outcome.
In the present study, acidic gelatin/β-TCP sponges with rhF-GF-2 significantly increased newly formed bone compared to basic gelatin/β-TCP sponges with rhFGF-2 in a concaved alveolar ridge 
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